Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4307)
All Articles published online
|
Nov 21, 2006 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang L, Zhu JS, Song MQ, Chen GQ, Chen JL. Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray. World J Gastroenterol 2006; 12(43): 6949-6954 [PMID: 17109515 DOI: 10.3748/wjg.v12.i43.6949] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i43/6949.htm |
| Number | Citing Articles |
| 1 |
Sadegh Fattahi, Monireh Golpour, Fatemeh Amjadi-Moheb, Marzieh Sharifi-Pasandi, Parastesh Khodadadi, Maryam Pilehchian-Langroudi, Gholam Hossein Ashrafi, Haleh Akhavan-Niaki. DNA Methyltransferases and Gastric Cancer: Insight Into Targeted Therapy. Epigenomics 2018; 10(11): 1477 doi: 10.2217/epi-2018-0096
|
| 2 |
Hsuan-Hsiang Peng, Hao-Chin Yang, Darius Rupa, Chun-Han Yen, Ya-Wen Chiu, Wei-Jia Yang, Fuh-Jinn Luo, Ta-Chun Yuan. ACK1 upregulated the proliferation of head and neck squamous cell carcinoma cells by promoting p27 phosphorylation and degradation. Journal of Cell Communication and Signaling 2022; 16(4): 567 doi: 10.1007/s12079-022-00670-6
|
| 3 |
Yan Cui, Ying Ying, Andrew van Hasselt, Ka Man Ng, Jun Yu, Qian Zhang, Jie Jin, Dingxie Liu, Johng S. Rhim, Sun Young Rha, Myriam Loyo, Anthony T. C. Chan, Gopesh Srivastava, George S. W. Tsao, Grant C. Sellar, Joseph J. Y. Sung, David Sidransky, Qian Tao, Simon Williams. OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation. PLoS ONE 2008; 3(8): e2990 doi: 10.1371/journal.pone.0002990
|
| 4 |
Yan Qing YANG, Lan Jing ZHANG, Hui DONG, Chang Long JIANG, Zheng Gang ZHU, Jian Xin WU, Yun Lin WU, Jun Song HAN, Hua Sheng XIAO, Heng Jun GAO, Qing Hua ZHANG. Upregulated expression of S100A6 in human gastric cancer. Journal of Digestive Diseases 2007; 8(4): 186 doi: 10.1111/j.1751-2980.2007.00311.x
|
| 5 |
Lokman Varisli. Identification of New Genes Downregulated in Prostate Cancer and Investigation of Their Effects on Prognosis. Genetic Testing and Molecular Biomarkers 2013; 17(7): 562 doi: 10.1089/gtmb.2012.0524
|
| 6 |
Ivan P Gorlov, Kanishka Sircar, Hongya Zhao, Sankar N Maity, Nora M Navone, Olga Y Gorlova, Patricia Troncoso, Curtis A Pettaway, Jin Young Byun, Christopher J Logothetis. Prioritizing genes associated with prostate cancer development. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-599
|
| 7 |
Suhaida A. Selamat, Janice S. Galler, Amit D. Joshi, M. Nicky Fyfe, Mihaela Campan, Kimberly D. Siegmund, Keith M. Kerr, Ite A. Laird-Offringa, Wael El-Rifai. DNA Methylation Changes in Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, and Lung Adenocarcinoma. PLoS ONE 2011; 6(6): e21443 doi: 10.1371/journal.pone.0021443
|
| 8 |
M Tarabichi, M Saiselet, C Trésallet, C Hoang, D Larsimont, G Andry, C Maenhaut, V Detours. Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer. British Journal of Cancer 2015; 112(10): 1665 doi: 10.1038/bjc.2014.665
|
| 9 |
Lei Gao, Jialin Meng, Yong Zhang, Junfei Gu, Zhenwei Han, Xiaolu Wang, Shenglin Gao. Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer. Genomics 2020; 112(6): 4980 doi: 10.1016/j.ygeno.2020.08.034
|
| 10 |
Rajat K. De, Anupam Ghosh. Linguistic recognition system for identification of some possible genes mediating the development of lung adenocarcinoma. Information Fusion 2009; 10(3): 260 doi: 10.1016/j.inffus.2008.11.007
|
| 11 |
Stine H. Kresse, Hege O. Ohnstad, Erik B. Paulsen, Bodil Bjerkehagen, Karoly Szuhai, Massimo Serra, Karl‐Ludwig Schaefer, Ola Myklebost, Leonardo A. Meza‐Zepeda. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization. Genes, Chromosomes and Cancer 2009; 48(8): 679 doi: 10.1002/gcc.20675
|
| 12 |
Jung Woo Eun, Ho-Sang Jeong, Eun-Jung Kim, Young Min Ahn, Won Sang Park, Jung Young Lee, Suk Woo Nam. Evaluation and application of RNAs derived from laser microdissected specimens using DNA microarray for expression genomics. BioChip Journal 2010; 4(4): 322 doi: 10.1007/s13206-010-4409-0
|
| 13 |
Elisa Zanini, Louay S. Louis, Jane Antony, Evdoxia Karali, Imoh S. Okon, Arthur B. McKie, Sebastian Vaughan, Mona El-Bahrawy, Justin Stebbing, Chiara Recchi, Hani Gabra. The Tumor-Suppressor Protein OPCML Potentiates Anti–EGFR- and Anti–HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer. Molecular Cancer Therapeutics 2017; 16(10): 2246 doi: 10.1158/1535-7163.MCT-17-0081
|
| 14 |
Jin-Shui Zhu, Hua Guo, Ming-Quan Song, Guo-Qiang Chen, Qun Sun, Qiang Zhang. Gene profiles between non-invasive and invasive colon cancer using laser microdissection and polypeptide analysis. World Journal of Gastroenterology 2008; 14(38): 5887-5892 doi: 10.3748/wjg.14.5887
|
| 15 |
Narayan Behera. Principles and Methods for Data Science. Handbook of Statistics 2020; 43: 349 doi: 10.1016/bs.host.2020.02.002
|
| 16 |
Juliane Sarah Stickel, Andreas O. Weinzierl, Nina Hillen, Oliver Drews, Mathias M. Schuler, Jörg Hennenlotter, Dorothee Wernet, Claudia A. Müller, Arnulf Stenzl, Hans-Georg Rammensee, Stefan Stevanović. HLA ligand profiles of primary renal cell carcinoma maintained in metastases. Cancer Immunology, Immunotherapy 2009; 58(9): 1407 doi: 10.1007/s00262-008-0655-6
|
| 17 |
Zheng Fang, Shuai Yin, Ruochuan Sun, Shangxin Zhang, Min Fu, Youliang Wu, Tao Zhang, Junaid Khaliq, Yongxiang Li. miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1. Molecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0708-6
|
| 18 |
Daniel SW Tan, Benjamin Haaland, Jia Min Gan, Su Chin Tham, Indrajit Sinha, Eng Huat Tan, Kiat Hon Lim, Angela Takano, Sai Sakktee Krisna, Minn Minn Myint Thu, Hoe Peng Liew, Axel Ullrich, Wan-Teck Lim, Boon Tin Chua. Bosutinib inhibits migration and invasion via ack1 in kras mutant non-small cell lung cancer. Molecular Cancer 2014; 13(1) doi: 10.1186/1476-4598-13-13
|
| 19 |
Leijie Li, Yujia Zhang, Yongyong Ren, Zhiwei Cheng, Yuening Zhang, Xinbo Wang, Hongyu Zhao, Hui Lu. Pan-Cancer Single-Cell Analysis Reveals the Core Factors and Pathway in Specific Cancer Stem Cells of Upper Gastrointestinal Cancer. Frontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.849798
|
| 20 |
Xiangbin Xing, Weibin Cai, Sanmei Ma, Yongfei Wang, Huijuan Shi, Ming Li, Jinxia Jiao, Yang Yang, Longshan Liu, Xiangliang Zhang, Minhu Chen. Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3203-y
|
| 21 |
Natalia Castaño-Rodríguez, Georgia L. Popple, Gloria Liliana Porras-Hurtado, José Luis Cardona-Deazza, Juan José Montoya-Martinez, Antonio Javier Cadavid-Velez, Héctor William Toro-Hidalgo, Alba Ruth Cobo-Alvarado, Ofelia del Socorro Hincapié-Rincón, Stephen M. Riordan, Nadeem O. Kaakoush. OPCML is hypermethylated in a subset of patients with metaplastic changes in their esophagus. Biomarker Research 2018; 6(1) doi: 10.1186/s40364-018-0150-y
|
| 22 |
Jean S Fleming, H James McQuillan, Melanie J Millier, Grant C Sellar. Expression of ovarian tumour suppressor OPCML in the female CD-1 mouse reproductive tract. REPRODUCTION 2009; 137(4): 721 doi: 10.1530/REP-08-0511
|
| 23 |
WEIDONG CHEN, ZHAOQING TANG, YIHONG SUN, YOUYOU ZHANG, XUEFEI WANG, ZHENBIN SHEN, FENGLIN LIU, XINYU QIN. miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes. Experimental and Therapeutic Medicine 2012; 3(2): 351 doi: 10.3892/etm.2011.411
|
| 24 |
Ferdinand von Eggeling, Christian Melle, Günther Ernst. Microdissecting the proteome. PROTEOMICS 2007; 7(16): 2729 doi: 10.1002/pmic.200700079
|
| 25 |
Patricia S Steeg, Dan Theodorescu. Metastasis: a therapeutic target for cancer. Nature Clinical Practice Oncology 2008; 5(4): 206 doi: 10.1038/ncponc1066
|
| 26 |
Bin Wang, Tao Xu, Jingfeng Liu, Shengbing Zang, Lingyun Gao, Aimin Huang. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma. Pathology - Research and Practice 2014; 210(12): 787 doi: 10.1016/j.prp.2014.09.014
|
| 27 |
Fengqing Hu, Hongcheng Liu, Xiao Xie, Ju Mei, Mingsong Wang. Activated cdc42-associated kinase is up-regulated in non-small-cell lung cancer and necessary for FGFR-mediated AKT activation. Molecular Carcinogenesis 2016; 55(5): 853 doi: 10.1002/mc.22327
|
| 28 |
Ferdinand von Eggeling, Franziska Hoffmann. Microdissection—An Essential Prerequisite for Spatial Cancer Omics. PROTEOMICS 2020; 20(17-18) doi: 10.1002/pmic.202000077
|
| 29 |
Xingming Zhang, Xiaoxue Yin, Haoran Zhang, Guangxi Sun, Yaojing Yang, Junru Chen, Xudong Zhu, Peng Zhao, Jinge Zhao, Jiandong Liu, Ni Chen, Jia Wang, Pengfei Shen, Hao Zeng. Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5578-4
|
| 30 |
Ying Pan, Ye Meng, Zhimin Zhai, Shudao Xiong. Identification of a three-gene-based prognostic model in multiple myeloma using bioinformatics analysis. PeerJ 2021; 9: e11320 doi: 10.7717/peerj.11320
|
| 31 |
He Yang, Wen Tian, Baosen Zhou. Sarcopenia and a 5-mRNA risk module as a combined factor to predict prognosis for patients with stomach adenocarcinoma. Genomics 2022; 114(1): 361 doi: 10.1016/j.ygeno.2021.12.011
|
| 32 |
Mark Aspinall‐O'Dea, Eithne Costello. The pancreatic cancer proteome – recent advances and future promise. PROTEOMICS – Clinical Applications 2007; 1(9): 1066 doi: 10.1002/prca.200700144
|
| 33 |
Weiyan Huang, Mei Zhao, Na Wei, Xiaoxia Wang, Huqing Cao, Quan Du, Zicai Liang, Chandravanu Dash. Site-Specific RNase A Activity Was Dramatically Reduced in Serum from Multiple Types of Cancer Patients. PLoS ONE 2014; 9(5): e96490 doi: 10.1371/journal.pone.0096490
|
| 34 |
Julia E. Maxson, Melissa L. Abel, Jinhua Wang, Xianming Deng, Sina Reckel, Samuel B. Luty, Huahang Sun, Julie Gorenstein, Seamus B. Hughes, Daniel Bottomly, Beth Wilmot, Shannon K. McWeeney, Jerald Radich, Oliver Hantschel, Richard E. Middleton, Nathanael S. Gray, Brian J. Druker, Jeffrey W. Tyner. Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis. Cancer Research 2016; 76(1): 127 doi: 10.1158/0008-5472.CAN-15-0817
|
| 35 |
J-S. Zhu, Z-P. Xu, M-Q. Song, Q. Zhang. Effect of Oxymatrine Combined with Low Dose 5-FU on Lymphatic Vessel and Microvascular Endothelial Cell Growth of Gastric Cancer in a Severe Combined Immunodeficient Mouse Orthotopic Implantation Model. European Journal of Inflammation 2011; 9(1): 45 doi: 10.1177/1721727X1100900107
|
| 36 |
Mei-Yu Tseng, Shyun-Yeu Liu, Hau-Ren Chen, Yu-Jen Wu, Chien-Chih Chiu, Po-Ting Chan, Wei-Fan Chiang, Yu-Chi Liu, Chien-Yu Lu, Yuh-Shan Jou, Jeff Yi-Fu Chen. Serine protease inhibitor (SERPIN) B1 promotes oral cancer cell motility and is over-expressed in invasive oral squamous cell carcinoma. Oral Oncology 2009; 45(9): 771 doi: 10.1016/j.oraloncology.2008.11.013
|
| 37 |
Chelsea Jenkins, Samuel B. Luty, Julia E. Maxson, Christopher A. Eide, Melissa L. Abel, Corinne Togiai, Eneida R. Nemecek, Daniel Bottomly, Shannon K. McWeeney, Beth Wilmot, Marc Loriaux, Bill H. Chang, Jeffrey W. Tyner. Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia. Science Signaling 2018; 11(539) doi: 10.1126/scisignal.aao5617
|
| 38 |
Boon Tin Chua, Shu Jing Lim, Su Chin Tham, Wei Jie Poh, Axel Ullrich. Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells. Molecular Oncology 2010; 4(4): 323 doi: 10.1016/j.molonc.2010.03.001
|
| 39 |
Wei Cao, Dan Zhou, Weiwei Tang, Hanxiang An, Yun Zhang. Discovery of plasma messenger RNA as novel biomarker for gastric cancer identified through bioinformatics analysis and clinical validation. PeerJ 2019; 7: e7025 doi: 10.7717/peerj.7025
|
| 40 |
Bin Lian, Hong Li, Yaobang Liu, Dahai Chai, Yali Gao, Yangyang Zhang, Jia Zhou, Jinping Li. Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer. Breast Cancer 2021; 28(2): 448 doi: 10.1007/s12282-020-01179-9
|